Perbak Capital Partners »

Soleno Therapeutics shares owned by Perbak Capital Partners

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Perbak Capital Partners from 13F filings

Historical chart of Perbak Capital Partners investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Perbak Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Perbak Capital Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $351k 5.2k 67.60

More positions owned by Perbak Capital Partners

Select Sector Spdr Tr Indl (XLI)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Ishares Tr Russell 2000 Etf (IWM)
Spdr Series Trust S&p Ins Etf (KIE)
Select Sector Spdr Tr Technology (XLK)
Elanco Animal Health (ELAN)
Ishares Tr Ishares Semicdtr (SOXX)
Select Sector Spdr Tr Financial (XLF)
Ubs Group SHS (UBS)
Qiagen Nv Com Shs (QGEN)
D.R. Horton (DHI)
Mettler-Toledo International (MTD)

View all positions for Perbak Capital Partners

Top funds holding Soleno Therapeutics

FMR
Henderson Group
BlackRock
Vanguard Group
venBio Select Advisor
Wellington Management Company
Vivo Capital
State Street Corporation
Invesco
Caption Management
Adage Capital Partners GP
Commodore Capital
Braidwell
Millennium Management
Polar Capital Holdings

View all funds holding Soleno Therapeutics